Prasad Raju bought CRSP

March 14, 2024 · Form 4 insider transaction

Prasad Raju bought 10,000 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction

Acquired (buy-side)

10,000

Price

N/A

Total value

N/A

InsiderPrasad Raju

RoleOfficer

CompanyCRISPR Therapeutics AG (CRSP)

SecurityCommon Shares

Transaction codeM: Option exercise

Transaction dateMarch 14, 2024

Filing dateMarch 18, 2024

Shares owned after10,000

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

View the original Form 4 on SEC EDGAR